List view / Grid view

Dimitrios Georgiopoulos

 

news

NICE recommends Novartis’ heart failure drug, Entresto

The UK’s National Institute for Health and Care Excellence (NICE)…

21 March 2016 | By Victoria White

The UK’s National Institute for Health and Care Excellence (NICE) has recommended Novartis’ heart failure drug, Entresto (sacubitrial/valsartan).

news

EC grants marketing authorisation to Entresto

The European Commission has granted marketing authorisation to Novartis’ Entresto…

25 November 2015 | By Victoria White

The European Commission has granted marketing authorisation to Novartis’ Entresto (sacubitril/valsartan) for the treatment of adult patients with symptomatic chronic heart failure with reduced ejection fraction (HFrEF).